膀胱癌临床与病理分期差异的研究进展

王艳龙; 黄灶明; 关升; 杨帆; 孙伟; 田洪雨; 蒋翔; 唐喆; 杨晓伟; 张志明; 廉征宇; 孙卫兵

膀胱癌临床与病理分期差异的研究进展

- 大连医科大学附属第二医院泌尿外科(辽宁大连, 116023)

详细信息

通讯作者: 孙卫兵,E-mail:massurm@163.com

中图分类号: R737.14

收稿日期: 2010-12-20

Corresponding author: , E-mail: massurm@163.com

Received Date: 20 December 2010

摘要

摘要: 膀胱癌是人类常见恶性肿瘤之一，具有复发性和多发性特点。膀胱癌的复发和进展与分期、分级有密切关系，不同分期的膀胱癌生物行为有较大差异，治疗上应区别对待。因此，正确的分期和分级是选择合适治疗方法的前提和基础。目前文献中膀胱癌分期差异报道较少，本文着重介绍膀胱癌分期差异产生的来源，以及评价各种分期工具在膀胱癌中的应用，以期使膀胱癌分期更为准确，为患者治疗方法的正确选择提供依据。
- 膀胱癌 /
- 临床分期 /
- 病理分期 /
- 分期差异 /
- 准确性

HTML全文

参考文献(37)

[1]	VAN RHIJN B W,BURGER M,LOTAN Y,et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer:from epidemiology to treatment strategy[J]. Eur Urol,2009,56:430-442.
[2]	SHARIAT S F,PALAPATTU G S,KARAKIEWICZ P I,et al. Discrepancy between clinical and pathologic stage:impact on prognosis after radical cystectomy[J]. Eur Urol,2007,51:137-149;discussion 149-151.
[3]	程天江,韩兴权,宋振才. 彩色多普勒超声与X-线膀胱造影和CT扫描对照诊断膀胱癌的临床价值[J]. 中国超声医学杂志,2004,20(6):449-452.
[4]	YAMAN O,BALTACI S,ARIKAN N,et al. Staging with computed tomography,transrectal ultrasonography and transurethral resection of bladder tumour:comparison with final pathological stage in invasive bladder carcinoma[J]. Br J Urol,1996,78:197-200.
[5]	杜联芳,周洋,李凡,等. 超声造影判断膀胱癌浸润程度及分期[J]. 中国医学影像技术,2007,23(12):1853-1855.
[6]	刘明,闫伟,于京赢,等. CT对膀胱癌局部分期的准确性及影响因素分析[J]. 临床泌尿外科杂志,2009,24(6):439-441.
[7]	Ng C S. Radiologic diagnosis and staging of renal and bladder cancer[J]. Semin Roentgenol,2006,41:121-138.
[8]	TEKES A,KAMEL I,IMAM K,et al. Dynamic MRI of bladder cancer:evaluation of staging accuracy[J]. AJR Am J Roentgenol,2005,184:121-127.
[9]	TAKEUCHI M,SASAKI S,ITO M,et al. Urinary bladder cancer:diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade[J]. Radiology,2009,251:112-121.
[10]	JAGER G J,BARENTSZ J O,OOSTERHOF G O,et al. Pelvic adenopathy in prostatic and urinary bladder carcinoma:MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence[J]. AJR Am J Roentgenol,1996,167:1503-1507.
[11]	LIEDBERG F,MÅNSSON W. Lymph node metastasis in bladder cancer[J]. Eur Urol,2006,49:13-21.
[12]	SWINNEN G,MAES A,POTTEL H,et al. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer[J]. Eur Urol,2010,57:641-647.
[13]	KIBEL A S,DEHDASHTI F,KATZ M D,et al. Prospective study of[18F] fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma[J]. J Clin Oncol,2009,27:4314-4320.
[14]	DESERNO W M,HARISINGHANI M G,TAUPITZ M,et al. Urinary bladder cancer:preoperative nodal staging with ferumoxtran-10-enhanced MR imaging[J]. Radiology,2004,233:449-456.
[15]	HARISINGHANI M G,BARENTSZ J,HAHN P F,et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer[J]. N Engl J Med,2003,348:2491-2499.
[16]	SAGA Y,NUMATA A,TOKUMITSU M,et al. Comparative study of novel endoluminal ultrasonography and conventional transurethral ultrasonography in staging of bladder cancer[J]. Int J Urol,2004,11:597-601.
[17]	FANG Y C,CHOU Y H,HSU C C,et al. Staging of bladder cancer by transabdominal real-time ultrasound[J]. Zhonghua Yi Xue Za Zhi(Taipei),1993,52:21-25.
[18]	PAIK M L,SCOLIERI M J,BROWN S L,et al. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy[J]. J Urol,2000,163:1693-1696.
[19]	KIM B,SEMELKA R C,ASCHER S M,et al. Bladder tumor staging:comparison of contrast-enhanced CT,T1-and T2-weighted MR imaging,dynamic gadolinium-enhanced imaging,and late gadolinium-enhanced imaging[J]. Radiology,1994,193:239-245.
[20]	TANIMOTO A,YUASA Y,IMAI Y,et al. Bladder tumor staging:comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT[J]. Radiology,1992,185:741-747.
[21]	HAYASHI N,TOCHIGI H,SHIRAISHI T,et al. A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil:a comparison with ultrasonography[J]. BJU Int,2000,85:32-36.
[22]	TEKES A,KAMEL I,IMAM K,et al. Dynamic MRI of bladder cancer:evaluation of staging accuracy[J]. AJR Am J Roentgenol,2005,184:121-127.
[23]	WATANABE H,KANEMATSU M,KONDO H,et al. Preoperative T staging of urinary bladder cancer:does diffusion-weighted MRI have supplementary value[J]? AJR Am J Roentgenol,2009,192:1361-1366.
[24]	HOFER C,KVBLER H,HARTUNG R,et al. Diagnosis and monitoring of urological tumors using positron emission tomography[J]. Eur Urol,2001,40:481-487.
[25]	BARENTSZ J O,WITJES J A,RUIJS J H. What is new in bladder cancer imaging[J]. Urol Clin North Am,1997,24:583-602.
[26]	HUSBAND J E. Computer tomography and magnetic resonance imaging in the evaluation of bladder cancer[J]. J Belge Radiol,1995,78:350-355.
[27]	DESERNO W M,HARISINGHANI M G,TAUPITZ M,et al. Urinary bladder cancer:preoperative nodal staging with ferumoxtran-10-enhanced MR imaging[J]. Radiology,2004,233:449-456.
[28]	THOENY H C,TRIANTAFYLLOU M,BIRKHAEUSER F D,et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients[J]. Eur Urol,2009,55:761-769.
[29]	DRIESKENS O,OYEN R,VAN POPPEL H,et al. FDG-PET for preoperative staging of bladder cancer[J]. Eur J Nucl Med Mol Imaging,2005,32:1412-1417.
[30]	PICCHIO M,TREIBER U,BEER A J,et al. Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer:correlation with histopathologic findings[J]. J Nucl Med,2006,47:938-944.
[31]	SWINNEN G,MAES A,POTTEL H,et al. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer[J]. Eur Urol,2010,57:641-647.
[32]	SATOH E,MIYAO N,TACHIKI H,et al. Prediction of muscle invasion of bladder cancer by cystoscopy[J]. Eur Urol,2002,41:178-181.
[33]	HERR H W,DONAT S M,DALBAGNI G. Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder[J]. J Urol,2002,168:978-980.
[34]	KRIEGMAIR M,BAUMGARTNER R,KNVCHEL R,et al. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence[J]. J Urol,1996,155:105-109;discussion 109-110.
[35]	FRADET Y, GROSSMAN H B, GOMELLA L, et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer:a phase III, multicenter study[J]. J Urol, 2007, 178:68-73.
[36]	GONO K,OBI T,YAMAGUCHI M,et al. Appearance of enhanced tissue features in narrow-band endoscopic imaging[J]. J Biomed Opt,2004,9:568-577.
[37]	那彦群,郭震华主编. 实用泌尿外科学[M]. 北京:人民卫生出版社,2009:287-287.